Warning: This product has not been approved or cleared for marketing by the U.S. Food and Drug Administration and is considered an investigational device.
Click here

Board of Directors

Paul Ashton

CEO, Inflammasome Therapeutics

Tasneem Dohadwala

Founding Partner, Excelestar Ventures

Bill McCullen

Chief Investment Officer, PV Capital Management

Josh Phillips

Founder, Catalyst Health Ventures

Sameer Sabir

CEO, Brixton Biosciences

Ruben Salinas

CEO, EyeCool Therapeutics

Vance Thompson, MD

Founder, Vance Thompson Vision

Josh Tolkoff

CIMIT Accelerator Executive